News and Announcements
Cogniss supports Luke Priddis Foundation to help young people with ASD
- Published August 03, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
More than 200,000 Australians are living with Autism Spectrum Disorder (ASD), a condition that affects an individual’s ability to communicate and interact with others.
Luke Priddis Foundation (LPF) is a non-profit organization that has been working to improve the lives of young people with ASD.
With Cogniss’ support, LPF will be moving away from its current paper-based format of delivering social stories — narratives that describe various social scenarios for young people with ASD. These narratives teach essential social-emotional skills such as making friends, coping with changes, and controlling impulses.
Delivering these stories via an app can not only make them more interactive and engaging but also improve learning outcomes.
During a recent workshop with Cogniss, the team at LPF participated in an exercise to create story apps. Brittany Talab, LPF’s General Manager, said, “We enjoyed creating the apps with the Cogniss team. The experience to be part of finding creative, modern solutions for our clients is what excites us here at LPF.
“The app allows our clients and therapists to use technology to communicate and problem solve. This tool and skill will benefit many clients, their families, and their therapists.”
LPF also plans to educate young people with ASD to create their own Cogniss apps so they can create social stories and share their experiences with others.
We are excited to support LPF in its vision of providing these young people a better chance at living independently.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
